NASDAQ : GH
Guardant Health, Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 178.8 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 23.99B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 23.99B |
| Enterprise Value | 24.64B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 134.20M |
| Shares Outstanding | 134.20M |
| Shares Change (YoY) | +4.62% |
| Shares Change (QoQ) | +1.21% |
| Owned by Insiders (%) | 3.47% |
| Owned by Institutions (%) | 100.93% |
| Float | 129.48M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.28 |
| Forward PS | 15.50 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 20.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.03 |
| Quick Ratio | 3.53 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -97.39 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -18.07% |
| Return on Invested Capital (ROIC) | -23.43% |
| Return on Capital Employed (ROCE) | -29.81% |
| Weighted Average Cost of Capital (WACC) | 12.12% |
| Revenue Per Employee | $472,109 |
| Profits Per Employee | -$180,940 |
| Employee Count | 2,506 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 4.37 |
Taxes
| Measure | Value |
|---|
| Income Tax | -1.03M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.58 |
| 52-Week Price Change | +147.41% |
| 50-Day Moving Average | 169.71 |
| 200-Day Moving Average | 130.50 |
| Relative Strength Index (RSI) | 57.25 |
| Average Volume (20 Days) | 1,779,909 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 11.67M |
| Short Previous Month | 11.92M |
| Short % of Shares Out | 8.70% |
| Short % of Float | 9.01% |
| Short Ratio (days to cover) | 6.12 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.18B |
| Gross Profit | 769.16M |
| Operating Income | -469.03M |
| Pretax Income | -454.47M |
| Net Income | -453.44M |
| EBITDA | -430.57M |
| EBIT | -469.03M |
| Loss Per Share | -$3.50 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.05B |
| Total Debt | 1.70B |
| Net Cash | -643.54M |
| Net Cash Per Share | -$4.80 |
| Equity (Book Value) | -222.87M |
| Book Value Per Share | -1.67 |
| Working Capital | 1.03B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -185.19M |
| Capital Expenditures | -55.54M |
| Depreciation & Amortization | 38.46M |
| Net Borrowing | 402.50M |
| Free Cash Flow | -240.72M |
| FCF Per Share | -$1.79 |
Margins
| Measure | Value |
|---|
| Gross Margin | 65.01% |
| Operating Margin | -39.64% |
| Pretax Margin | -38.41% |
| Profit Margin | -38.33% |
| EBITDA Margin | -36.39% |
| EBIT Margin | -39.64% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.62% |
| Shareholder Yield | -4.62% |
| Earnings Yield | -1.96% |
| FCF Yield | -1.00% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $202.24 |
| Price Target Difference | 13.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 26 |
| Revenue Growth Forecast (3Y) | 36.44% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.28 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |